Bacteriology Asia Pacific 2019

Call for Papers

Bacteriology has inevitably been impacted by the genomic revolution, with the first microbial genome sequencing project, that of Haemophilus influenzae, being completed in 1995. While microbes are thought to make up approximately 60% of the earth’s biomass, less than 1% of them have been characterized thus far. Currently, a number of agencies are continuing the enormous task of mapping these DNA sequences, particularly those that are of medical importance, or have the potential to be used in bioterrorism.

Studies of bacterially-produced human proteins are continuing, with many new proteins expected to enter the treatment armamentarium in the coming years. Viruses are being utilized as vectors for the delivery of therapeutic genes for the treatment of a variety of illnesses. Bacteriophages are also being developed for the treatment of bacterial infections. The development of resistance to current treatment strategies is set to continue, and will become a greater problem in the future unless new treatment methods are developed. It is to be hoped that genetic research will aid scientists in combating this problem.

Research into the extreme diversity of microbial organisms will lead to the elucidation of new biologic pathways and gene products, and thus potential therapeutic strategies to combat or prevent infection